FDA’s AEMS Updated for Consolidated Adverse Event Monitoring
The FDA’s AEMS platform consolidates adverse event reporting beyond just integrating FAERS. Explore its impact on safety signals and pharmacovigilance.
FDA MedWatch: Adverse Event Reporting at the Centre of Drug Safety
The FDA’s MedWatch supports drug and device safety through voluntary reports, mandatory industry submissions, and safety alerts. Explore its role in MedSafety Week 2026.
AI in GMP Manufacturing: Are Regulators Ready for Digital Factories?
Learn how AI in pharmaceutical GMP manufacturing is improving quality, data integrity, predictive maintenance, and regulatory compliance in modern drug production.
Pharmaceutical Quality Control Powering Supply Resilience
Pharmaceutical quality control now shapes supply performance. Learn what World Quality Week 2026 means for testing, PAT, and batch release decisions today.
Pharmaceutical Quality Management Systems
Find out how pharmaceutical quality management connects ISO standards, GMP, QMS, and CAPA to prevent manufacturing failures and support consistent medicine quality.
Endpoints in Gynaecological Oncology Clinical Trials
Gynaecological oncology clinical trials reveal that survival gains and trial design do not always align. Here is what clinical development teams should learn.